News
In the final quarter before merging with Aphria, Tilray shows fiscal weakness
Hi, what are you looking for?
In the final quarter before merging with Aphria, Tilray shows fiscal weakness
After posting an industry-leading US$260M in Q1, the American weed giant eyes domination in NY, NJ and internationally
While medical cannabis is excluded from the pharmaceutical supply chain, the deal sets a precedent for other health care institutions to follow suit
Pure Sunfarms will double capacity by 2022, despite oversupply issues and fierce competition in the Canadian pot market
With revenue of US$1.2B in 2021, Trulieve says the combined company will rival Curaleaf as America's biggest legal weed seller
With revenue of just US$12.6M in Q1, the Canadian pot firm says it's finally ready to commercialize its synthetic cannabinoids joint venture
Calgary-based producer will get 86 Spiritleaf pot shops that Inner Spirit owns and franchises
But Chris Damas of the BCMI Cannabis Report notes the Aphria-merged firm will command a strong presence in Europe's medical cannabis market
The major US weed firm adds its 13th state and strong footing in the first adult-use market set to launch in the South
Since receiving $221M from British American Tobacco, the Canadian cannabis firm has reported declining revenue
